| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.44B | 120.59B | 124.25B | 103.36B | 86.50B | 83.06B |
| Gross Profit | 12.48B | 11.95B | 12.19B | 7.27B | 6.22B | 7.05B |
| EBITDA | 7.81B | 7.64B | 8.32B | 4.75B | 4.84B | 6.17B |
| Net Income | 136.00M | 56.00M | 2.48B | -3.60B | -8.02B | -1.04B |
Balance Sheet | ||||||
| Total Assets | 80.42B | 83.71B | 81.93B | 81.45B | 79.54B | 74.54B |
| Cash, Cash Equivalents and Short-Term Investments | 14.22B | 14.94B | 12.40B | 11.65B | 12.31B | 10.60B |
| Total Debt | 24.66B | 24.75B | 23.87B | 30.72B | 29.34B | 20.96B |
| Total Liabilities | 47.23B | 49.17B | 50.87B | 55.23B | 52.16B | 41.62B |
| Stockholders Equity | 33.19B | 34.54B | 31.06B | 26.22B | 27.38B | 32.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.56B | 8.85B | 474.00M | -5.41B | -1.22B |
| Operating Cash Flow | 0.00 | 6.15B | 11.48B | 5.47B | 1.31B | 5.29B |
| Investing Cash Flow | 0.00 | -3.59B | -2.75B | -5.10B | -6.87B | -5.86B |
| Financing Cash Flow | 0.00 | -959.00M | -8.40B | -1.66B | 6.38B | 1.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥46.87B | 16.81 | ― | 3.36% | 7.18% | 29.03% | |
79 Outperform | ¥431.41B | 11.25 | ― | 1.60% | -5.16% | 200.96% | |
75 Outperform | ¥494.22B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
73 Outperform | ¥144.39B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥8.22B | 4.65 | ― | 4.24% | -7.88% | -73.98% | |
57 Neutral | ¥19.07B | 18.77 | ― | 3.19% | -8.99% | -62.26% |